These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2994375)

  • 1. Bone mineral content and estrogen receptors in women with breast tumors.
    Nielsen HE; Saksø P; Skorgaard Poulsen H; Gadeberg CC
    Acta Radiol Oncol; 1985; 24(3):247-51. PubMed ID: 2994375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total and local bone mineral during estrogen treatment: a placebo controlled trial.
    Gotfredsen A; Riis BJ; Christiansen C
    Bone Miner; 1986 Apr; 1(2):167-73. PubMed ID: 3334206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral content and estrogen receptors in patients with breast cancer.
    Nielsen HE; Poulsen HS; Olsen KJ; Gadeberg CC; Schultz H
    Eur J Cancer (1965); 1979 May; 15(5):703-7. PubMed ID: 510332
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer.
    Gotfredsen A; Christiansen C; Palshof T
    Cancer; 1984 Feb; 53(4):853-7. PubMed ID: 6692287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral content in hyperthyroid patients after combined medical and surgical treatment.
    Nielsen HE; Mosekilde L; Charles P
    Acta Radiol Oncol Radiat Phys Biol; 1979; 18(2):122-8. PubMed ID: 495190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between estrogen receptor concentration in breast cancer tissue and bone mineral density.
    Sriussadaporn S; Srimuninnimit V; Ploybutr S; Tanlakit M; Chearskul S; Chakrapee-Sirisuk S; Nitiyanant W; Vannasaeng S; Sinlarat P; Vichayanrat A
    J Med Assoc Thai; 2002 Mar; 85(3):327-33. PubMed ID: 12117021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
    Abul-Hajj YJ
    Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between local and total bone mineral in normal pubertal boys.
    Krabbe S; Gotfredsen A; Christiansen C
    Eur J Pediatr; 1984 Dec; 143(2):149-51. PubMed ID: 6335091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosol and nuclear estrogen receptors (occupied and unoccupied sites) and progesterone receptors in human breast cancer.
    Sumida C; Magdelenat H; Pasqualini JR
    Breast Cancer Res Treat; 1985; 5(2):165-9. PubMed ID: 4016282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile periodontitis: skeletal bone mineral content.
    Von Wowern N; Stoltze K
    J Clin Periodontol; 1977 Nov; 4(4):272-7. PubMed ID: 271654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Representativity of regional to total bone mineral in healthy subjects and 'anticonvulsive treated' epileptic patients. Measurements by single and dual photon absorptiometry.
    Gotfredsen A; Borg J; Nilas L; Tjellesen L; Christiansen C
    Eur J Clin Invest; 1986 Jun; 16(3):198-203. PubMed ID: 3089816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptors in human breast cancer. Correlation with histologic subtype and degree of differentiation.
    Mohammed RH; Lakatua DJ; Haus E; Yasmineh WJ
    Cancer; 1986 Sep; 58(5):1076-81. PubMed ID: 3015374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of lactation on bone mineral content in healthy postpartum women.
    Hayslip CC; Klein TA; Wray HL; Duncan WE
    Obstet Gynecol; 1989 Apr; 73(4):588-92. PubMed ID: 2927853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal bone loss at multiple skeletal sites: relationship to estrogen use.
    Wasnich R; Yano K; Vogel J
    J Chronic Dis; 1983; 36(11):781-90. PubMed ID: 6643645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer.
    Skinner JR; Wanebo HJ; Betsill WL; Wilhelm MC; Drake CR; Macleod RM
    Ann Surg; 1982 Dec; 196(6):636-41. PubMed ID: 7149814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover.
    Naeraa RW; Brixen K; Hansen RM; Hasling C; Mosekilde L; Andresen JH; Charles P; Nielsen J
    Calcif Tissue Int; 1991 Aug; 49(2):77-83. PubMed ID: 1913298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between local and total bone mineral content after gastric surgery.
    Nilas L; Gotfredsen A; Christiansen C
    Scand J Gastroenterol; 1984 Jul; 19(5):591-5. PubMed ID: 6474080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, estrogen production, and tumor estrogen receptors in women with carcinoma of the breast.
    Donegan WL; Johnstone MF; Biedrzycki L
    Am J Clin Oncol; 1983 Feb; 6(1):19-24. PubMed ID: 6837504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical factors related to the presence of estrogen receptors in breast cancer: a prognostic stratification analysis.
    Pascual MR; Lazo R; Fernandez L; Lage A
    Neoplasma; 1982; 29(4):453-61. PubMed ID: 7133236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.